Maravai LifeSciences Holdings Inc <MRVI.OQ> expected to post a loss of 7 cents a share - Earnings Preview
Maravai LifeSciences Holdings Inc MRVI.OQ MRVI.O is expected to show a fall in quarterly revenue when it reports results on May 12 for the period ending March 31 2025
The San Diego California-based company is expected to report a 31.4% decrease in revenue to $44.009 million from $64.18 million a year ago, according to the mean estimate from 13 analysts, based on LSEG data.
LSEG's mean analyst estimate for Maravai LifeSciences Holdings Inc is for a loss of 7 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 7 "hold" and 1 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Maravai LifeSciences Holdings Inc is $5.00, above its last closing price of $1.98.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Dec. 31 2024 | -0.04 | -0.04 | -0.06 | Missed | -50 |
Sep. 30 2024 | -0.01 | -0.01 | -0.02 | Missed | -160.1 |
Jun. 30 2024 | 0.00 | 0.00 | 0.00 | Met | -100 |
Mar. 31 2024 | -0.03 | -0.03 | -0.02 | Beat | 21.4 |
Dec. 31 2023 | -0.01 | -0.01 | 0.01 | Beat | 184.6 |
Sep. 30 2023 | 0.00 | 0.01 | -0.01 | Missed | -257.2 |
Jun. 30 2023 | 0.01 | 0.01 | 0.00 | Missed | -100 |
Mar. 31 2023 | 0.04 | 0.04 | 0.03 | Missed | -17.2 |
This summary was machine generated May 9 at 23:44 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Related Articles
What is a Spot ETF for Altcoins? Which Tokens Might the SEC Approve for Spot ETFs?
a spot ETF for altcoins tracks the prices of altcoins and can be traded on stock exchanges. Once approved, these ETFs will be listed on platforms like Nasdaq and the New York Stock Exchange, not just on cryptocurrency exchanges like Coinbase and Binance.
Tesla Q1 2025 Earning Report Review: Autonomous Driving and Robotics Lead Future Growth
TradingKey - Tesla's Q1 2025 earnings results revealed short-term financial pressure, with core data lower than market expectations, and both revenue and profitability facing challenges. Against the backdrop of sales and profit pressure, Musk remains confident in Tesla's future.
Tesla's 2025 Q1 Earning Report Preview: A Critical Moment of Hope and Challenge
TradingKey - Tesla's 2025 Q1 financial report will be released on April 22. As a leader in the global electric vehicle industry, its performance has attracted much attention from the market.
TSMC 2025 Q1 Outlook: AI-Driven Growth and Supply Chain Breakthrough Amid Tariff Pressures
As the world's leading semiconductor foundry, TSMC's Q1 2025 revenue reached NT$839.254 billion, a year-on-year increase of 41.6%, exceeding market expectations and in line with the company's guidance of NT$820 billion to NT$846.24 billion.
